Avantium wins Amsterdam Inventor Award 2009
Award for new generation biofuels and bioplastics.June 19, 2009 - Amsterdam, The Netherlands
On Thursday Avantium received from Mayor Cohen the Amsterdam Inventor Award 2009 for the most prominent invention of 2008.
During the Inventor Dinner, R&D companies and organizations presented their most important discoveries. Participating organizations were among others Royal Dutch Shell, Corus, Kiadis, Logica, University of Amsterdam, VU University of Amsterdam, and Academic Medical Centre Amsterdam (AMC).
Gert-Jan Gruter, Avantium Chief Technology Officer: "The Amsterdam Inventor Award is an important recognition for Avantium and the potential of our biofuels and biopolastics. Our furanics technology is a tremendous breakthrough for biobased products and it has enormous market potential. The coming years we will work together with industrial partners to commercialize this invention.
Avantium develops "furanics", a new generation of bioplastics and biofuels. Furanics can be produced from biomass such as sugars and other carbohydrates. By using cellulose and agricultural rest streams Avantium can make furanics from biomass that does not compete with food chains. Avantium's furanics bioplastics can be produced cheaper than oil-based plastics and they have attractive properties with the potential to replace traditional plastics in many existing applications. Avantium's furanics biofuel program aims to develop a new generation of biofuels with both excellent properties (such as high energy density and mixability with conventional fuels) and competitive production costs. Engine tests have demonstrated that furanics is an attractive fuel component for existing combustion engines.
Furanics are a sustainable alternative for materials and fuels that are currently produced from crude oil. Furanics reduce the dependence on oil and have a positive impact to lower CO2 emissions.
About Avantium
Avantium is a leading technology company specialized in the area of advanced high-throughput R&D. The company develops and commercializes furanics, a next generation biofuels and bioplastics, and develops improved forms of existing drugs. Avantium has demonstrated the value and commercial potential of its unique technology and knowledge by collaborating with leading companies in the energy, chemical and pharmaceutical industry. Avantium's customer base for its R&D services and systems offering consists of more than 70 companies worldwide, including market leaders such as BP, Shell, Sasol, Pfizer and GSK. In 2008, the company generated revenues of approximately EUR 19 million. Avantium has around 140 employees; its offices and headquarters are based in Amsterdam, the Netherlands.
For more information
Please contact Anniek Gielkens at +31 6 14496444, or visit our website: www.avantium.com

